Your browser doesn't support javascript.
loading
A common presentation - turning out as an uncommon diagnosis: From hip pain to Langerhans cell histiocytosis.
Volis, Ina; Livneh, Ido; Zohar, Yaniv; Raz-Pasteur, Ayelet.
Afiliação
  • Volis I; Department of Internal Medicine "A", Rambam Health Care Campus, Haifa 3109601, Israel; The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 3109602, Israel; Department of Cardiology, Rambam Health Care Campus, Haifa, Israel. Electronic address: i
  • Livneh I; The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 3109602, Israel. Electronic address: idoliv@campus.technion.ac.il.
  • Zohar Y; The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 3109602, Israel; Department of Pathology, Rambam Health Care Campus, Haifa, Israel. Electronic address: y_zohar@rambam.health.gov.il.
  • Raz-Pasteur A; Department of Internal Medicine "A", Rambam Health Care Campus, Haifa 3109601, Israel; The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 3109602, Israel. Electronic address: a_raz@rambam.health.gov.il.
Am J Med Sci ; 364(3): 353-358, 2022 09.
Article em En | MEDLINE | ID: mdl-35472335
Langerhans cell histiocytosis (LCH) is an uncommon clonal proliferation of myeloid progenitor cells, it is especially rare in adults. We present a case of multi-system LCH in a 53-year-old woman, the sole symptom of which was prolonged, non-resolving hip pain for 18 months prior to the diagnosis. Initial evaluation included imaging studies aimed at identifying a presumed local etiology. X-ray demonstrated non-specific arthritic changes on the left femur. Computed tomography (CT) and magnetic resonance imaging (MRI) scans identified a lytic lesion at the same location, warranting a systemic workup. After non-invasive investigations failed to reveal the underlying etiology, a biopsy was performed, revealing cores of Langerhans cells that stained positive for both CD1a and langerin. These findings verified the surprising, uncommon diagnosis of LCH. A comprehensive workup was conducted in order to determine the extent of the disease and its molecular nature - revealing a BRAFV600E-positive, high-risk, multi-system LCH with skeletal, lung and liver involvement.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans Idioma: En Ano de publicação: 2022 Tipo de documento: Article